Corticoide e gestacao

NIH Consensus Statement
Volume 12, Number 2 February 28–March 2, 1994

Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

NATIONAL INSTITUTES OF HEALTH Office of the Director

About the NIH Consensus Development Program
NIH Consensus Development Conferences are convened to evaluate available scientific information and to resolve safety and efficacy issues related to a biomedical technology. The resultant NIH Consensus Statements are intended to advance understanding of the technology or issue in question and to be useful to health professionals and the public. NIH Consensus Statements are prepared by a nonadvocate, non-Federal panel of experts, based on (1) presentations by investigators working in areas relevant to the consensus questions during a 2-day public session; (2) questions and statements from conference attendees during open discussion periods that are part of the public session; and (3) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. Free copies of this statement and bibliographies prepared by the National Library of Medicine are available from the Office of Medical Applications of Research, National Institutes of Health, Federal Building, Room 618, Bethesda, MD 20892, or the NIH Consensus Program Information Service at 1-800-NIH-OMAR (644-6627). A catalog of other free NIH Consensus Statements is also available from these sources. For making bibliographic reference to the consensus statement from this conference, it is recommended that the following format be used, with or without source abbreviations, but without authorship attribution: Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. NIH Consens Statement 1994 Feb 28–Mar 2; 12(2):1–24.

NIH Consensus Statement
Volume 12, Number 2 February 28–March 2, 1994

Effect of